Department of Periodontology, University of Bern, Bern, Switzerland.
Department of Periodontology, Dental Research Division, School of Dentistry, Veiga de Almeida University, Rio de Janeiro, Brazil.
Clin Oral Investig. 2020 Aug;24(8):2543-2557. doi: 10.1007/s00784-020-03400-7. Epub 2020 Jun 26.
The aim of this systematic review and meta-analysis was to compare the use of platelet-rich fibrin (PRF) with other commonly utilized treatment modalities for root coverage procedures.
The eligibility criteria comprised randomized controlled trials (RCTs) comparing the performance of PRF with that of other modalities in the treatment of Miller class I or II (Cairo RT I) gingival recessions. Studies were classified into 5 categories as follows: (1) coronally advanced flap (CAF) alone vs CAF/PRF, (2) CAF/connective tissue graft (CAF/CTG) vs CAF/PRF, (3) CAF/enamel matrix derivative (CAF/EMD) vs CAF/PRF, (4) CAF/amnion membrane (CAF/AM) vs CAF/PRF, and (5) CAF/CTG vs CAF/CTG/PRF. Studies were evaluated for percentage of relative root coverage (rRC; primary outcome), clinical attachment level (CAL), keratinized mucosa width (KMW), and probing depth (PD) (secondary outcomes).
From 976 articles identified, 17 RCTs were included. The use of PRF statistically significantly increased rRC and CAL compared with CAF alone. No change in KMW or reduction in PD was reported. Compared with PRF, CTG resulted in statistically significantly better KMW and RC. No statistically significant differences were reported between the CAF/PRF and CAF/EMD groups or between the CAF/PRF and CAF/AM groups for any of the investigated parameters.
The use of CAF/PRF improved rRC and CAL compared with the use of CAF alone. While similar outcomes were observed between CAF/PRF and CAF/CTG for CAL and PD change, the latter group led to statistically significantly better outcomes in terms of rRC and KTW. In summary, the use of PRF in conjunction with CAF may represent a valid treatment modality for gingival recessions exhibiting adequate baseline KMW.
The data indicate that the use of PRF in conjunction with CAF statistically significantly improves rRC when compared with CAF alone but did not improve KMW. Therefore, in cases with limited baseline KMW, the use of CTG may be preferred over PRF.
本系统评价和荟萃分析旨在比较富血小板纤维蛋白(PRF)与其他常用于根覆盖术的治疗方法的使用效果。
纳入标准包括比较 PRF 与其他方法在治疗 Miller Ⅰ类或Ⅱ类(开罗 RT I)牙龈退缩中的表现的随机对照试验(RCT)。研究分为以下 5 类:(1)冠向推进瓣(CAF)单独与 CAF/PRF,(2)CAF/结缔组织移植物(CAF/CTG)与 CAF/PRF,(3)CAF/ enamel 基质衍生物(CAF/EMD)与 CAF/PRF,(4)CAF/羊膜膜(CAF/AM)与 CAF/PRF,以及(5)CAF/CTG 与 CAF/CTG/PRF。研究评估了相对根覆盖百分比(rRC;主要结果)、临床附着水平(CAL)、角化黏膜宽度(KMW)和探诊深度(PD)(次要结果)。
从 976 篇文章中,共纳入 17 项 RCT。与单独使用 CAF 相比,使用 PRF 可显著增加 rRC 和 CAL。未报告 KMW 或 PD 的变化。与 PRF 相比,CTG 导致 KMW 和 RC 明显更好。在 CAF/PRF 和 CAF/EMD 组或 CAF/PRF 和 CAF/AM 组之间,任何研究参数均未报告统计学显著差异。
与单独使用 CAF 相比,使用 CAF/PRF 可提高 rRC 和 CAL。虽然 CAF/PRF 和 CAF/CTG 组在 CAL 和 PD 变化方面的结果相似,但后者在 rRC 和 KTW 方面的结果明显更好。总之,在基线 KMW 充足的情况下,使用 CAF 联合 PRF 可能是治疗牙龈退缩的一种有效方法。
数据表明,与单独使用 CAF 相比,使用 PRF 联合 CAF 可显著提高 rRC,但未改善 KMW。因此,在基线 KMW 有限的情况下,可能优先使用 CTG 而不是 PRF。